Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotics Treatment of Cholangitis Post-Kasai Portoenterostomy
NCT04370145Phase 4Completed
- Sponsor
- Tongji Hospital
- Start
- May 2021
- Primary completion
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of meropenem, teicoplanin in cholangitis, sponsored by Tongji Hospital. Started May 2021; status: completed.
02
Drugs
meropenemteicoplanin
03
Conditions
cholangitis
Beyond the preview
Go deeper on NCT04370145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04370145.